http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007052104-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d424cbf0a95e6b38b417df8e72d9ff45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e5ac7b69eb01020a0966307ac575251
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
filingDate 2006-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_972477d8fe42b6195e8322b31a4247e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7920e8fecbe6e623da4a868cacca917b
publicationDate 2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007052104-A3
titleOfInvention Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1h-[1,8]naphthyridin-2-one
abstract The present application relates to crystalline salts of 7-[4-(4-naphthalen-l- yl-piperazin-l-yl)-butoxy]-3,4-dihydro-lH-[l,8]naphthyridin-2-one, process for preparation of the crystalline salts, pharmaceutical compositions containing the crystalline salts, and use of the crystalline salts for treating certain disorders or conditions.
priorityDate 2005-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005019215-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11697676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129896039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426182042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127697018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90945392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244467858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227390897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248688290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91074497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245406148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127487301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID299643

Total number of triples: 38.